Virtu Financial’s Jasper Therapeutics JSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-347
Closed -$306K – 1599
2024
Q1
$306K Buy
+347
New +$185K 0.02% 610
2023
Q3
– Sell
-36
Closed -$15K – 1594
2023
Q2
$15K Buy
+36
New +$16K ﹤0.01% 1307
2023
Q1
– Sell
-48
Closed -$7K – 1794
2022
Q4
$7K Sell
48
-1
-2% -$201 ﹤0.01% 1423
2022
Q3
$12K Buy
+49
New +$26.9K ﹤0.01% 1495
2022
Q1
– Sell
-69
Closed -$163K – 1757
2021
Q4
$163K Buy
+69
New +$194K 0.02% 918

Other funds holding JSPR

Virtu Financial's JSPR Position: Q2 2024 in Review

Virtu Financial sold out of Jasper Therapeutics (JSPR) in Q2 2024, closing a stake of 347 shares — an estimated $306K sold.

Virtu Financial first reported a position in JSPR in Q4 2021 and held it in 5 quarters. The position peaked at $306K in Q1 2024. 69 funds tracked by Wall St. Rank hold JSPR as of Q2 2024.

  • Virtu Financial reported no remaining Jasper Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Virtu Financial sold 347 Jasper Therapeutics shares in Q2 2024, an estimated $306K.
  • Virtu Financial first reported a position in Jasper Therapeutics in Q4 2021 and held it in 5 quarters.
  • Virtu Financial's Jasper Therapeutics position peaked at $306K in Q1 2024.
  • 69 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.